Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3692863014 | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3692864015 | Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
468572010 | Betamethasone+neomycin sulfate 0.1/0.5% cream | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
468572010 | Betamethasone+neomycin sulfate 0.1/0.5% cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
468573017 | Betamethasone+neomycin sulphate 0.1/0.5% cream | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
468573017 | Betamethasone+neomycin sulphate 0.1/0.5% cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
721436015 | Betamethasone+neomycin sulfate 0.1/0.5% cream (substance) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1192596012 | Betamethasone+neomycin sulfate 0.1/0.5% cream (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1192596012 | Betamethasone+neomycin sulfate 0.1/0.5% cream (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3692863014 | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3692864015 | Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3692865019 | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Betamethasone+neomycin sulfate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Betamethasone | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Adrenal hormone | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Corticosterone | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Adrenal hormone agent | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | anti-infectieux cutané | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Neomycin | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Local anti-infective | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Bactericide | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Glucocorticoid hormone | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Betamethasone- and neomycin-containing product | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | forme pharmaceutique pour usage transdermique et/ou cutané | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Topical neomycin | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Topical betamethasone | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | Cutaneous cream | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Product containing betamethasone valerate in topical dosage form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Betamethasone valerate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit (attribute) | g | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Neomycin sulphate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit (attribute) | g | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator value | cinq | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Neomycin sulphate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Betamethasone | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Product containing only betamethasone and neomycin in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Existential restriction modifier (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets